Skip to content

BD Angiocath 382259Recalls & reported problems

Becton, Dickinson And Company · ANGIOCATH SPECIAL GRAY 16GA X 5.25IN · Class 2

All models of BD Angiocath (8)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00382903822591), received between Aug 20, 2019 and Aug 14, 2025 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break1
  • Contamination1
  • Device Contamination with Chemical or Other Material1
  • Leak/Splash1

Patient problems

  • Device Embedded In Tissue or Plaque1
  • No Clinical Signs, Symptoms or Conditions1
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 14, 2025Contamination; Contamination

    NO ADDITIONAL INFORMATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22806890 ↗
  • InjuryOct 30, 2019Break; Break

    IT WAS REPORTED THAT DURING USE OF THE ANGIOCATH SPECIAL GRAY 16GA X 5.25IN AS IT WAS REMOVED THE NEEDLE BROKE. FORCEPS WERE USE TO REMOVE THE BROKEN NEEDLE FROM THE PATIENT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM FRENCH TO ENGLISH: WHEN PERFORMING A NEPHROSTOMY, THE RADIOLOGIST STABBED THE PATIENT'S KIDNEY TRANSCUTANEOUSLY. AFTER REMOVAL OF THE MANDREL, THE NEEDLE SEPARATED FROM THE PLASTIC SUPPORT LOCATED AT THE END OF THE MANDREL AND STRAIGHTENED IN THE BODY OF THE PATIENT. THE MANDREL HAD TO BE REMOVED FROM THE PATIENT WITH A FORCEPS BUT THE MANEUVER WAS VERY DIFFICULT.

    Patient problems: Device Embedded In Tissue or Plaque

    MAUDE report 9255584 ↗
  • MalfunctionAug 20, 2019Leak/Splash; Device Contamination with Chemical or Other Material; Leak/Splash; Device Contamination with Chemical or Other Material

    IT WAS REPORTED THAT DURING USE OF THE ANGIOCATH SPECIAL GRAY 16GA X 5.25IN THE CUSTOMER COMPLAINED THAT IT BROKE DURING THORACENTESIS. FOREIGN COMPLAINT THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM CHINESE TO ENGLISH: THE CUSTOMER COMPLAINT THAT THE CATHETER BROKEN IN BODY DURING EXTUBATION OF THE THORACENTESIS.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8911427 ↗

Other Catheter,intravascular,therapeutic,short-term less than 30 days devices

All Catheter,intravascular,therapeutic,short-term less than 30 days devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page